Combination of post-operative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: A propensity score analysis.
Oral Oncology（2018）
Abstract
•Cetuximab targets the extracellular domain of the epidermal growth factor receptor.•High-risk cutaneous squamous cell cancers have a high risk of recurrence.•Combination of cetuximab and radiation may improve progression free and overall survival.
MoreTranslated text
Key words
Cutaneous squamous cell carcinoma,Head and neck,Post-operative radiotherapy,Cetuximab,Survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined